1157 related articles for article (PubMed ID: 24853936)
1. The intersection of amyloid beta and tau at synapses in Alzheimer's disease.
Spires-Jones TL; Hyman BT
Neuron; 2014 May; 82(4):756-71. PubMed ID: 24853936
[TBL] [Abstract][Full Text] [Related]
2. The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.
Crimins JL; Pooler A; Polydoro M; Luebke JI; Spires-Jones TL
Ageing Res Rev; 2013 Jun; 12(3):757-63. PubMed ID: 23528367
[TBL] [Abstract][Full Text] [Related]
3. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
4. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
[TBL] [Abstract][Full Text] [Related]
5. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
6. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.
Gouras GK; Tampellini D; Takahashi RH; Capetillo-Zarate E
Acta Neuropathol; 2010 May; 119(5):523-41. PubMed ID: 20354705
[TBL] [Abstract][Full Text] [Related]
7. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
10. Synaptic tau: A pathological or physiological phenomenon?
Robbins M; Clayton E; Kaminski Schierle GS
Acta Neuropathol Commun; 2021 Sep; 9(1):149. PubMed ID: 34503576
[TBL] [Abstract][Full Text] [Related]
11. Synaptic oligomeric tau in Alzheimer's disease - A potential culprit in the spread of tau pathology through the brain.
Colom-Cadena M; Davies C; Sirisi S; Lee JE; Simzer EM; Tzioras M; Querol-Vilaseca M; Sánchez-Aced É; Chang YY; Holt K; McGeachan RI; Rose J; Tulloch J; Wilkins L; Smith C; Andrian T; Belbin O; Pujals S; Horrocks MH; Lleó A; Spires-Jones TL
Neuron; 2023 Jul; 111(14):2170-2183.e6. PubMed ID: 37192625
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
Rajmohan R; Reddy PH
J Alzheimers Dis; 2017; 57(4):975-999. PubMed ID: 27567878
[TBL] [Abstract][Full Text] [Related]
13. Spines, plasticity, and cognition in Alzheimer's model mice.
Spires-Jones T; Knafo S
Neural Plast; 2012; 2012():319836. PubMed ID: 22203915
[TBL] [Abstract][Full Text] [Related]
14. Synaptic degeneration in Alzheimer disease.
Tzioras M; McGeachan RI; Durrant CS; Spires-Jones TL
Nat Rev Neurol; 2023 Jan; 19(1):19-38. PubMed ID: 36513730
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
16. Dendritic Tau in Alzheimer's Disease.
Ittner A; Ittner LM
Neuron; 2018 Jul; 99(1):13-27. PubMed ID: 30001506
[TBL] [Abstract][Full Text] [Related]
17. Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony.
Forner S; Baglietto-Vargas D; Martini AC; Trujillo-Estrada L; LaFerla FM
Trends Neurosci; 2017 Jun; 40(6):347-357. PubMed ID: 28494972
[TBL] [Abstract][Full Text] [Related]
18. Early Alzheimer-type lesions in cognitively normal subjects.
Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C
Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845
[TBL] [Abstract][Full Text] [Related]
19. Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease.
Xie J; Wang H; Lin T; Bi B
Biomed Res Int; 2017; 2017():2986460. PubMed ID: 28473983
[TBL] [Abstract][Full Text] [Related]
20. A role for tau at the synapse in Alzheimer's disease pathogenesis.
Pooler AM; Noble W; Hanger DP
Neuropharmacology; 2014 Jan; 76 Pt A():1-8. PubMed ID: 24076336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
